Abstract Many people suVer from Wbromyalgia (FM) without an eVective treatment. They do not have a good quality of life and cannot maintain normal daily activity. Among the diVerent hypotheses for its ethiopathophysiology, oxidative stress is one of the possibilities. Non-scientiWc information addressed to patients regarding the beneWts of nutrition is widely available, and they are used to trying non-evidenced strategies. The aim of this paper is to Wnd out what we know right now from scientiWc studies regarding Wbromyalgia disease and nutritional status, diets and food supplements. A systematic search has been performed on Medline with a wide range of terms about these nutritional issues. The search has been made during 2009, for articles published between 1998 and 2008. Target population: people suVering from FM. Vegetarian diets could have some beneWcial eVects probably due to the increase in antioxidant intake. There is a high prevalence of obesity and overweight in patients, and weight control seems to be an eVective tool to improve the symptoms. Some nutritional deWciencies have been described, it is not clear whether they are directly related to this disease or not. About the usefulness of some food supplements we found very little data, and it seems that more studies are needed to prove which ones could be of help. Dietary advice is necessary to these patients to improve their diets and maintain normal weight. It would be interesting to investigate more in the Weld of nutrition and FM to reveal any possible relationships.
Introduction
Over the 1970s, Wbromyalgia syndrome (FM) began to be identiWed as a distinct clinical syndrome, diVerent from other rheumatic illnesses. The WHO and all international medical organisations did not recognise it as a disease until 1992. Nowadays it is classiWed as a rheumatic disease with an unknown aetiology and without an eVective medical treatment. FM is a condition characterised by widespread pain in 11 of 18 tender points experienced for at least 3 months [1] . The 1990 American College of Rheumatology classiWcation criteria are widely used for the diagnosis of Wbromyalgia and provide a sensitivity and speciWcity of nearly 85% diVerentiating FM from other forms of chronic musculoskeletal pain. As well as pain, patients commonly report some other symptoms such as fatigue, sleep disorders, depression, anxiety, cognitive diYculties, headache, low back pain, and illnesses like irritable bowel syndrome, chronic fatigue syndrome, rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis. FM has an enormous impact on the quality of life (QOL) of patients who experience a reduced functionality or capacity to carry on the activities of daily living; every day activity becomes more diYcult, more time consuming or simply impossible.
Fibromyalgia syndrome and rheumatoid arthritis are among the most common causes of musculoskeletal pain and disability. The prevalence of FM has not been determined using a large or international population base, but it is commonly estimated to aVect 1-2% of the population [2] [3] [4] [5] , although some studies show higher Wgures, even up to 5% [6, 7] . In Spain it is calculated to aVect 2.4% of the general population [8] [9] [10] , although in other studies the Spanish prevalence seems to be around 4% or more [11] . The results in an Italian survey study show a prevalence of 2.2% [12] . Also, a very recent study estimates that the prevalence of FM in the French population is 1.4% [13] . Women are more likely than men to have FM and patients with FM are more likely to have one or more comorbid conditions such as depression, anxiety, headache, irritable bowel syndrome, chronic fatigue syndrome, systemic lupus erythematosus and rheumatoid arthritis [2] . The absence of FM in China is an interesting issue, which could be explained by genetic diVerences and, maybe, by sociocultural diVerences. It could be worthwhile to study and compare the prevalence gradients from China to the ones in the western world, which might provide important insights into what causes this disease [14] .
Since FMS aetiology and physiopathology are unknown, it is diYcult to Wnd an eVective and curative treatment, either pharmacological or non-pharmacological. There is an interesting hypothesis about the pathophysiologic mechanism, which is widespread in the scientiWc literature, the oxidative stress hypothesis. Some studies try to explain how oxidative stress (OE) may be involved in the development and maintenance of this syndrome. For instance, it has been observed that some FM patients had lower levels of some antioxidant nutrients like magnesium and selenium [15, 16] . They also seem to have an insuYcient antioxidant status [17] , a predominance of a pro-oxidative status [18] , and a lower antioxidant capacity [19] . The results indicate that these patients have a high level of oxidative stress and perhaps the high levels of free radicals in their bodies may be involved in the development of the disease. Some studies have investigated thoroughly the mechanisms of cellular oxidation. Nitric oxide (NO) and its derivative peroxinitrite (ONOO ¡ ) are often said to have a relevant role in this process. ONOO ¡ is a powerful oxidant agent which is the result of the combination of the NO and the superoxide radical (O 2 ¡ ). These agents seem to act as initiators of an oxidation reactions cycle which is not totally counteracted by the antioxidant defences. This may be a potential cause of the development of FM and also of chronic fatigue syndrome (CFS) [20] [21] [22] .
Some of the studies indicated above consider that an antioxidant supplementation might be beneWcial in the treatment of FM, because of its high oxidative stress status as well as its inXammation level. In relation to this, there are data from nutritional interventions in which antioxidant intake was increased through a vegetarian diet, with positive results on rheumatic and FMS patients [23, 24] . However, this is a matter that would need more evaluation.
The case that in CFS patients as well as FM patients there is a high level of oxidative stress seems widely proved. However, it is unknown whether it is a cause or a consequence. The musculoskeletal symptoms are related not only to an increase in oxidative stress but also to a decrease in the antioxidant defences [25] . OE causes cellular damage, aVecting a wide range of levels and functions like the lipidic peroxidation, cell membrane functionality and prostaglandin synthesis [26] . Another study shows that the higher level of OE or prooxidant substances in erythrocytes damages them and alters their normal functionality, contributing to the CFS symptoms [27] .
Since the discovery of mitochondrial disfunction, medicine has advanced in the understanding of the roles of these cellular organelles in some diseases and in ageing. Some illnesses, like FM and CFS, seem to have common pathophysiological mechanisms, which involve free radicals, their accumulation in mitochondria and DNA damage [20] . More than 90% of cell energy is produced in mitochondria, through oxidative phosphorylation and through the coordination of two close processes, the tricarboxylic acid cycle (or Krebs cycle) and the electron transport chain, involving diVerent reactions, enzymes, coenzymes and nutrients acting as cofactors. In the Krebs cycle cysteine, iron, niacin, magnesium, manganese, thiamine, riboXavin, pantothenic acid, lipoic acid and L-carnitine are all involved. In the electron transport chain, coenzyme Q10, Xavines, copper and iron, among others are of a high importance. The correct functioning of all these reactions depends on the presence of high enough quantities of these nutrients. During the oxidative phosphorylation process, consumed oxygen is converted into superoxide radicals, but the mitochondria have mechanisms to eliminate this in aqueous form, with the help of the superoxide dismutase (SOD-Mn) and the glutathione peroxidase (GPX). These antioxidant enzymes are very important because mitochondrial lipids, proteins, enzymes and DNA are especially vulnerable to free radical action. The mitochondria may lose functionality when their components are damaged, and this could lead to a feedback process that causes additional injuries. When the superoxide radical is not suYciently neutralised by these protective mitochondrial processes, it combines with nitric oxide leading to the more oxidant free radical, peroxinitrite, and therefore to an oxidative stress situation in cells.
Apart from oxidative stress, another theory for the pathophysiologic mechanism of FM is the immunological theory, involving inXammatory cytokines. Although very few studies have shown elevated cytokine levels in FM, the data available suggest that a high chemokine level may play a causative role in this disease [28, 29] . Cytokines are known to play a role in diverse clinical processes and phenomena such as fatigue, fever, sleep, pain, stress and aching. A review of the FM literature and related studies suggest that IL-1, IL-6 and IL-8 are deregulated in the syndrome. Therefore, therapies directed against these cytokines may be of potential importance in the management of FM and could be more closely studied in the future [30] .
In relation to the management of the disease, recent reviews show which interventions are more eVective by reducing the symptoms of the disease, mainly pain but also fatigue and cognitive damage, and also reveal the fact that multidimensional approaches are the most appropriate to these patients. Some drugs, physical activity, relaxation techniques and cognitive behaviour therapy are the most useful tools [31, 32] . Although various pharmacological treatments have been studied for treating FMS, no single drug or group of drugs has proved to be useful in treating the disease as a whole. Several agents, including serotoninnorepinephrine reuptake inhibitors (i.e., duloxetine and milnacipran), opioids (i.e., tramadol) and the 2-ligand pregabalin have recently received the US Food and Drug Administration approval for treating the syndrome in the United States. They have been evaluated in clinical trials, showing a positive eVect in terms of pain reduction and improvement in core symptoms such as fatigue and sleep disturbance [33, 34] .
Regarding non-pharmacological therapeutic approaches there are some data from diVerent reviews. Some have demonstrated strong evidence for eYcacy, like cardiovascular exercise, cognitive behavioural therapy, patient education and multidisciplinary therapy. In addition, other adjunctive treatments show moderate evidence of eYcacy, like strength training, acupuncture, hypnotherapy, biofeedback and balneotherapy [35] . For other non-pharmacological approaches, widely used and potentially beneWcial, such as ozone therapy and some food supplements, more investigation is needed [36] .
In summary, at present there is no cure for FM and no universally eVective treatment, so physicians are searching for the best way to manage FM. There are some aspects that could need more investigation like, for example, how nutrition may aVect the clinical symptoms of these patients. Since this disease aVects a signiWcant proportion of the population, with various degrees of impact on disability and quality of life, it results in a signiWcant number of physician visits, work disability and medication use. Therefore it is of a crucial relevance to review what is known and to investigate what else could be done to improve health and quality of life in these patients.
The primary purpose of this review is to Wnd out what we know about the possible relationship between nutrition and FM, and to look at the main studies carried out on nutritional evaluation and intervention. In this report we have analysed the current knowledge related to this disease and diet, nutritional status and nutritional supplementation.
Experimental methods
Studies in humans were identiWed through a systematic and computerised search of MEDLINE. The languages of the studies selected were English as well as Spanish, and the range of publication date from 1998 to 2008. The main terms for the systematic search were FM in combination with nutrients, food intake, dietary patterns, nutritional supplementation, complementary medicine, vegan diet, antioxidants, dietary modiWcation, obesity, body mass index and others indicated in Table 1 . Only those papers which studied directly or indirectly the relationship we looked for were selected. Reference lists of the included articles were also scrutinised to search for relevant studies, and in some cases led to a new search to get new papers, or to contact authors for further details of their trials, in particular when the full study report was not available.
Results

Fibromyalgia, diet and nutrition
Fibromyalgia, as a rheumatoid disease where chronic inXammation and oxidative stress are main concerns, may have some beneWts from diets rich in antioxidants, like those based on uncooked vegan products called living food (LF) [23] . Patients eating LF showed higher levels of betaand alfa-carotenes, lycopen and lutein, vitamin C and vitamin E in their serum, than the controls eating a normal diet. Also, levels of polyphenolic compounds like quercetin, myricetin and kaempherol were much higher than in the omnivorous controls. Moreover, the clinical outcomes of this intervention for FM subjects were an improvement in their joint stiVness and pain as well as an improvement in their self-experienced health.
Due to this possibility of beneWt from the vegan diet rich in antioxidants in these patients, some other studies evaluated the eVects of vegan diets on the symptoms of FM. Two of them compared the eVect of changing an omnivorous diet for a vegetarian diet, without making any change in the medical treatment of the patients. The third compared the eVect of the vegetarian diet against the eVect of a pharmacological treatment with amitriptyline.
The Wrst one [37] , a non-randomised and controlled study, evaluated the eVect of a strict, low-salt, uncooked vegan diet rich in lactobacteria, on symptoms in 18 FM patients, during a 3-month intervention period. A 15-patient control group continued their omnivorous diet during the same time. The results were evaluated with a visual analogue scale (VAS) of pain, joint stiVness and quality of sleep, and with a health assessment questionnaire (HAQ), general health questionnaire (GHQ) and the rheumatologist's own questionnaire, indicating an improvement in the outcomes. Patients showed a reduction in body mass index (BMI), total cholesterol and urine sodium, indicating good diet compliance. In conclusion, the results suggested that a vegan diet has beneWcial eVects on FM symptoms, at least in the short run.
In the second study [24] , 30 people participated in a dietary intervention using a mostly raw, pure vegetarian diet, consisting of raw fruits, salads, carrot juice, tubers, grain products, nuts, seeds and a dehydrated barley grass juice product. The outcomes measured were dietary intake and diVerent disease/health scales such as the Wbromyalgia impact questionnaire (FIQ), the short form health survey (SF-36), a quality of life survey and a physical performance measurement. The intervention was of 7 months and after this period all the respondents, 19 out of 30 subjects, had a signiWcant improvement in all measured outcomes, except for body pain. At the end of the study the scores for all the scales, except body pain, were no longer statistically diVerent from healthy women aged 45-54. To carry on the dietary intervention, all the participants were informed at the beginning of the study, but they did not receive regular support meetings for motivational encouragement because the researchers considered that this might make the results less applicable to the general population. This study concluded that this sort of dietary intervention can help FM patients. Considering Donaldson's study, Bennett concluded that many FM patients could be helped by recommending a mostly raw vegetarian diet, but he encouraged the researchers to repeat the study with a control group. Although it is diYcult to design a double-blind placebo control for dietary studies, it would be interesting and possible to use a diVerent diet control group, distinct from the raw vegetarian one [38] .
For the third study, since it was known that brain tryptophan is low in FM, and intake of protein rich in large neutral amino acids has been reported to lower it, an open, randomised and controlled study [39] was undertaken to assess whether any reduction of such proteins by exclusion of animal protein from the diet reduced pain and morbidity in FM patients compared with the reduction by a pharmacological agent. Thirty-seven subjects with FM were enrolled in a vegetarian diet and 41 in a pharmacological amitriptyline treatment group. The outcome was assessed with the help of a tender point count, and VAS scale of frequencies of fatigue, insomnia, non-restorative sleep and pain. The diVerences were signiWcant at 6 weeks of treatment, showing improvement in the amitryptyline group. In the vegetarian diet group all of them were insigniWcant, except in pain score. However, the decrease in the pain score, though signiWcant, was much smaller than in the amitriptyline group. As a result, the authors concluded that due to the diVerences between both groups the vegetarian diet exclusively is a poor option in the treatment of FM.
Composition and alterations in the intestinal bacterial Xora are believed to be contributing factors to many chronic inXammatory and degenerative diseases, since the Xora act as an important immunologic protection barrier. However, the relationship between possible changes in intestinal Xora, secretion of immunoglobulin A, and speciWc illnesses is unknown. One study [40] was performed to test whether a Mediterranean diet and an 8-day fasting period led, in patients with rheumatoid arthritis or FM, to some changes in faecal Xora and in clinical outcome. A total of 51 patients participated and none of the two dietary interventions, in the way they were carried out, led to change, neither in the intestinal microXora nor in the clinical parameters tested. So the impact of dietary interventions on the human intestinal Xora and the role of this in rheumatic diseases still need to be clariWed. Monosodium glutamate (MSG) and aspartame could act as excitotoxin molecules in organisms, acting as excitatory neurotransmitters, and may lead to neurotoxicity when used in excess [41] . The elimination of MSG and aspartame from the diets of four FM patients with multiple co-morbidities produced a resolution of their symptoms within months after the intervention. It is known that intramuscular injection of glutamate into the human masseter muscle evokes muscle pain, which is stronger in women. However, the eVect of dietary glutamate consumption on these patients is not well known. When relatively high concentrations of glutamate are ingested without food, a short-lived increase in serum and intramuscular glutamate concentrations is observed. However, the eVects on tissue levels of dietary glutamate and the role in the development and maintenance of chronic musculoskeletal pain such as that in patients with FM are not well understood. This suggests that research with larger number of patients with similar conditions is needed to conWrm the eVectiveness of this dietary treatment [42, 43] .
Nowadays the internet has become a major source of information, and lots of patients with FM use some treatments that mostly lack scientiWc evidence. This is the case of the 'elimination diet', based on identifying and avoiding irritant foods for which these patients may have a subclinical allergy. It consists of a rotation of foods with close attention to the eVects; speciWc foods are introduced into the diet at the rate of 1 per 5 days. An "oligoantigenic" diet is another method of food therapy without scientiWc basis, in which modern manufactured foods are removed from the diet and replaced with the palaeolithic equivalents [44] . Moreover, in some websites, journals and books addressed to FM patients, information regarding the potential beneWt of macrobiotic diets and foods is frequently found. Despite this, in our search we have not found any article that deals with these issues. On a practical basis some patients are recommended to avoid those foods which cause them subjective worsening of their symptoms.
Mood, anxiety and eating disorders are of a higher prevalence in FM patients. There is a signiWcant co-occurrence of FM with some psychiatric disorders and eating disorders, such us nervous anorexia and bulimia which have a relevant incidence among this people [45] . It has been observed that binge eating disorders co-occurred signiWcantly with FM disease [46] . Therefore, on a practical level, if FM patients are more likely to have these eating disorders, special attention should be given to that when evaluating and treating them.
Fibromyalgia and nutritional status
A study based on an Internet survey addressed to people with FM, developed by the National Fibromyalgia Association (NFA) of the US, and responded to by about 2,500 participants, identiWed several issues for further research such as the prescribing habits of FM health care providers and the impact of obesity among others. In comparison with US National Census Wgures, respondents were moderately overweight 70% had a BMI >25, and 43% had a BMI >30; higher Wgures comparable with the general population [47] . Several other studies have reported obesity problems in FM [48] [49] [50] and others had reported that weight reduction provides improvement to these patients [51] . In fact, overweight and obesity are highly frequent in these people, and body mass index has a negative correlation with quality of life and tenderness threshold, and a positive correlation with physical dysfunction and pain point count. Obese FM patients show higher pain sensitivity and lower levels of quality of life [52] . The high prevalence of overweight and obesity was showed also in a health telephonic survey made only on female participants, with and without FM. However, up to now, it does not seem possible from available current data to determine whether weight gain, experimented in these persons, especially in women with FM, is due to the disease and its accompanying low activity levels, or whether those women are more prone to premorbid obesity than healthy ones [53] . Nevertheless, sound research has oVered us results on the improvement for multiple musculoskeletal complaints and function, usually measured as quality of life by a health questionnaire like SF-36, through weight loss in obese people [54] . It is known that obesity is associated with a range of disabling musculoskeletal conditions, like FM, especially in adults. As the prevalence of obesity increases, the social burden of these chronic musculoskeletal conditions, in terms of disability, health-related quality of life and health-care costs also increases. Therefore, weight reduction is an important tool in ameliorating some of the manifestations of musculoskeletal diseases and improving function and patients' quality of life [55] .
Another characteristic found in FM patients is a higher resting metabolic rate (RMR) compared with healthy controls. In both groups, RMR was measured by indirect calorimetry, and predicted RMR, by fat-free weight, sex, age, height and weight. This high measured RMR was not correlated with thyroid hormones TSH, FT4 and FT3 [56] . This study began with the hypothesis that FM patients could be hypometabolic due to hypothyroidism, because of some beneWcial results found in some thyroid hormone treatment trials. However, TSH, T3 and T4 levels did not signiWcantly diVer between patients and the control group.
Patients with FM commonly have a high body mass index and are physically inactive, which are two main risk factors for metabolic syndrome. Although there is not enough sound knowledge about the relationship between FM and metabolism, we found one study conducted on women with chronic pain from FM which concluded that they have an increased risk of suVering from metabolic syndrome. So it recommended that these people should be educated about the beneWts of physical exercise and weight loss, to reduce their metabolic risk as well as improve of pain and general health [57] .
Another important aspect of nutritional status is the possibility of some nutritional deWciencies. It has been proposed that some of them are involved in FM patient symptoms, although there is no study that globally evaluates them. We have found in this revision isolated studies that focus on the potential role in the pathogenesis of FM of some possible nutritional deWciencies such as for magnesium, iodine, iron, vitamin D, melatonin and branched chain amino acids.
Iodine deWciency is hypothesised to give rise to subtle impairment of thyroid function leading to clinical syndromes, like those in FM, without either biochemical alterations in T3, T4 and TSH or clinical manifestations such as goitre and cretinism [57] . It has also been pointed that selenium, zinc, iron or retinoic acid imbalance could lead to the clinical eVects of iodine deWciency due to their role in optimal thyroid function. It is known that the more symptoms of hypothyroidism are present, the more likely the presence of FM becomes [58] . There is not a total evidence of iodine deWciency in FM, but this issue deserves some attention because this nutritional impairment is a worldwide health problem.
Regarding iron, an increased frequency of FM in iron deWciency anaemia (IDA) and in thalassaemia minor (TM) was diagnosed in a study. Some non-speciWc symptoms of IDA and TM, like impaired cognitive function, fatigue or inability to concentrate, may not be explained by only anaemia, and consequently may not respond to therapy. In these cases considering the possibility of a FM diagnosis is recommended, since in this study the results show higher prevalence of FM in IDA and TM patients [59] . A second step will be to understand the role that iron replacement therapy could play in some cases suVering from FM and IDA or TM at the same time.
A pilot study concluded that FM was frequently associated with osteoporosis, and thus early detection and implementation of appropriate nutritional supplementation with calcium and vitamin D could be useful [60] . Vitamin D deWciency was found to be common in FM women, although they were not at an increased risk of developing osteoporosis or osteomalacia, since bone density in them was comparable with that in controls [61] . On the contrary, the highest prevalence of hypovitaminosis D, over 92.7%, was found in a group of people with non-speciWc musculoskeletal pain [62] . Although this study recommended urgent general screenings of FM patients and treatment with vitamin D for replenishment, it was criticised by other authors, which have obtained diVerent and contradictory results [63] . In those, low vitamin D levels were not associated with diVusing musculoskeletal pain, and treatment with this nutrient did not reduce pain [64] . Recent studies have conWrmed that FM patients have vitamin D deWciencies or insuYcient levels compared with local healthy references. Even within those with hypovitaminosis D there is a higher prevalence of anxiety and depression. Therefore, more clinical studies are needed to fully assess the impact of vitamin D in these patients, in order to reach a consensus and improved guidelines for rheumatologists [65, 66] .
Some trace elements have been supposed to have a relevant role in the pathophysiology of FM, especially those related to the redox balance in cells, like selenium, zinc and magnesium. An examination of serum levels of these three elements in FM patients showed that magnesium and zinc levels were decreased, compared with controls, and there was no considerable diVerence in selenium levels. Moreover, serum magnesium and zinc levels were associated with clinical parameters, indicating a possible role of these two trace elements in FM ethiopathogenesis [67] . However, this study did not evaluate whether there was a nutritional deWciency or a low magnesium or zinc intake from the diet. In our search we have not found any study on the possible deviation of nutrient intake in patients with FM, compared with recommendations for general population. On the other hand, another recent study could not conclude that there are abnormal levels of copper, iron, magnesium, selenium and zinc, among others, in blood or urine of FM patients. Although there were some diVerences between them and controls, they were of no clinical signiWcance. Therefore, these results gave no support to the hypothesis that trace elements unbalance could play a signiWcant role in the development of this disease [68] . Otherwise, some other data indicated that this is not a clear issue and contradictory results appeared regarding some trace element levels in this disease, showing some normal levels for Se and Mg [69] and others lower levels for Se [16] .
Nevertheless, these trace elements are highly important in maintaining the oxidants/antioxidants balance in the body. When the total antioxidant capacity is measured in these patients, it seems that they are exposed to a higher oxidative stress than healthy controls, reinforcing its possible role in etiopathogenesis and the possible positive eVectiveness of therapy with antioxidant vitamins such as vitamins C and E [19] .
Based on the hypothesis of possible tryptophan deWciency or metabolism disorders, one study investigated this issue by means of a nutritional intervention consisting of tryptophan depletion in patients with FM. The results showed some diVerences between FM patients and healthy subjects: IL-6 levels markedly increased during tryptophan depletion in FM patients but not in the control group. This increase seemed to be caused by the general setting of the amino acid beverage and not by the tryptophan depletion, as it was detected under this condition and also the sham depletion. Since both are objectively unpleasant, therefore, the IL-6 elevation may reXect the eVect of acute stress [70] . An altered response of IL-6 to a physiologic stressor supported the notion that FM may represent a primary disorder of the stress system [71] . Otherwise we have not found any study comparing the nutritional status with the inXammatory status of these patients.
Fibromyalgia pain has been related to a deWciency of serotoninergic function, with a lower total plasma tryptophan concentration, which is known to be its precursor, as well as a lower ratio of plasma tryptophan to the amino acids valine, leucine, isoleucine, phenylalanine and tyrosine, which compete with tryptophan for the same cerebral uptake mechanism. However, these results have not been conWrmed by other studies which evaluated them as well as plasma concentrations of the branched chain amino acids (BCCAs) [72] . Due to the possible malfunction of energy metabolism of the muscle Wbres of FM patients, it has been shown that a reduced plasma concentration of the branched chain amino acids, valine, leucine and phenylalanine exists in these people and could potentially contribute to muscle energy depletion. Although these results are very interesting, more studies are needed to conWrm that this deWciency might play a role in the pathophysiology of FM, and to clarify whether it is due to a low dietary intake or not, and whether supplementation with BCCAs could help these patients.
Lower levels of melatonin were also found in FM patients compared to normal controls and, although circadian disturbances cannot be the cause of FM, melatonin replacement reduced complaints. Because of the good safety proWle of melatonin, without either hangover or tolerance development, the authors recommended considering using it as treatment, even more in cases when a deWciency may occur, such as in people suVering from FM [73] .
Finally, we would like to highlight that although there is no a sound evidence of possible nutritional deWciencies in FM, there is enough data to encourage more investigation in this matter.
Fibromyalgia and nutritional supplementation
Since there is no therapeutic solution for the treatment of FM, a substantial amount of non-scientiWc literature has arisen concerned with the potential beneWts of some products based on nutritional ingredients or botanicals. However, when scientiWc information is searched in databases such as Medline, very few studies are found.
Our search was based on the most popular nutritional remedies, and the results are summarised in Table 2 . The reports found were about the use of Chlorella pyreinoidosa, 5-hydroxytryptophan (5-HTP), acetyl-L-carnitine, coenzyme Q10, Ginkgo biloba, collagen hydrolysate, ascorbigen and S-adenosyl-L-methionine. All of them reported possible beneWts for FM patients, ameliorating symptoms such as pain, fatigue, morning stiVness and quality of life, measured all with similar, but not equal, tests. Regarding 5-HTP we have included three articles dated before 1998, which are out of the time range of this review because they were used in Birdsall's review in 1998. At the moment, these reports are diYcult to compare because of the diVerences in some aspects such as assessment tools, clinical variables evaluated, doses, time for supplementation, among others.
Although there is not enough evidence for all the nutritional supplements mentioned above, these studies point to the possibility of using them to reduce FM symptoms. Therefore, it is generally observed that when some nutritional supplementation is used, whatever it is, patients frequently report positive eVects, mainly in pain, fatigue and capacity for carrying on their daily activities, although there is never a total recovery [87] . Positive eVects on chronic fatigue syndrome, but not directly on FM, have been described in some studies on diVerent nutritional supplements [88] .
Due to the possible relationship between a high oxidative stress and FM, some of the reports reviewed in this paper have recommended more investigation about the potential eVects of nutritional antioxidants supplementation. Nevertheless, in our search we have not found enough studies to thoroughly evaluate this hypothesis.
Discussion
Fibromyalgia reduces the quality of life of many people in the world and is an important current public health issue. It is a chronic rheumatic disease, but its cause is unknown. There is no an eVective treatment for this illness, and at the moment all the studies point to a multidimensional approach, recommending some pharmacological remedies as well as physical activity, relaxation techniques and other tools. In response to the large amount of non-scientiWc information regarding the possible beneWts of some diets, and food supplements for FM, the purpose of this review was to evaluate this hypothesised relationship between FM and nutritional factors.
The data reviewed suggest that some nutritional interventions, such as those focused on the maintenance of weight within normal ranges, could help on FM symptoms, even more so when it is known that within this population the prevalence of overweight and obesity, as well as some eating disorders, are higher than in the general population. Vegetarian diets also seem to have a positive eVect, but more complete studies are needed to conWrm this. Regarding the use and beneWts of elimination diets, based for example on identifying and avoiding potentially irritant food for these patients, we have not found any article dealing with these issues.
Some deWciencies have been proposed to be involved in FM patients, although we have not found any study that globally evaluates them. We have found isolated studies which point to possible nutritional deWciencies for magnesium, selenium, zinc, iodine, iron, vitamin D, melatonin, branched chain amino acids, etc. Moreover, FM is hypothesised to be associated with osteoporosis, hypothyroidism, anaemia, hyposerotoninergic function, and other metabolism disorders, although for none of them has a clear relationship been established.
The usefulness of some nutritional supplements has been evaluated in some studies, in general terms with positive results. Those we have found propose the use of some botanicals like Chlorella pyreinoidosa algae and gingko biloba, some antioxidants like coenzyme Q10 and ascorbigen, and other substances like acetyl-carnitine, collagen and S-adenosyl-L-methionine. However, none of the studies found are enough to generally recommend the use of a concrete food supplement in FM patients in order to reduce their symptoms. With the current data available, it is reasonable to recommend carrying on more clinical trials to evaluate the beneWts of a nutritional supplementation on this disease.
Since there is no a whole solution for the treatment of FM, and some of the studies reviewed show possible beneWts of diet, it seems reasonable to manage the dietary habits of these patients, to ensure an optimal nutrient intake, avoiding possible deWciencies and to help them maintain a healthy weight.
In summary, this review reveals a possible beneWt of improving dietary behaviour on normal weight maintenance in this population, and even using some nutritional supplementation to achieve an optimal nutritional status. This is encouraging, and therefore we suggest that more investigation is required in order to understand more details about the potential beneWts for FM from nutrition. We conclude that, at the moment, it is necessary to give dietary advice to these patients to improve their diets and maintain a normal weight as well as good health.
We would like also to note that due to our search being restricted to only the Medline database, there could be other relevant studies not evaluated in this paper.
